Rating Change
Freedom Capital Markets reiterated its Buy rating on Inspire Medical Systems, Inc. (NYSE:INSP) on November 13, 2026.
Freedom Capital Markets reiterated its Buy rating on Inspire Medical Systems, Inc. (NYSE:INSP) on November 13, 2026.

At publication ·
Inspire Medical Systems, Inc. (NYSE:INSP) · reiterate
At a glance
Freedom Capital Markets reiterated its Buy rating on Inspire Medical Systems, Inc. (NYSE:INSP) on November 13, 2026.
Inspire Medical Systems, Inc. operates in the Healthcare sector. The stock currently trades at $61.10 with a market capitalization of $4.1B. The stock has declined 33.2% over the past 52 weeks.
Analyst coverage from Freedom Capital Markets provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Inspire Medical Systems, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 1 Buy, 7 Hold, 2 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Nov 13, 2026 | Freedom Capital Markets | Buy | N/A |
| Nov 03, 2026 | Barclays | Underweight | N/A |
| Nov 03, 2026 | Evercore ISI Group | In-Line | N/A |
| Nov 03, 2026 | Truist Securities | Hold | N/A |
| Nov 03, 2026 | Wells Fargo | Equal-Weight | N/A |
Related Tools: Analyst Ratings Dashboard | View INSP Stock Page
A rating of Buy from Freedom Capital Markets reflects the analyst's outlook on Inspire Medical Systems, Inc. (NYSE:INSP). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the INSP forecast page.
Current market data
NYSE · INSP
$56.28
Down: -$1.83 · -3.15%
Live quote updated
Keep reading
analyst ·
analyst ·
analyst ·
earnings ·